Induction of histidine decarboxylase in macrophages inhibited by the novel NF-κB inhibitor (-)-DHMEQ

Biochemical and Biophysical Research Communications

Volumn 379, Issue 2, 2009, Pages 379-383

  Suzuki, Eriko ^a   Ninomiya, Yoko ^a   Umezawa, Kazuo ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

( ) DHMEQ; C EBP ; HDC; Macrophage; NF B

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; DEHYDROXYMETHYLEPOXYQUINOMICIN; HISTAMINE; HISTIDINE DECARBOXYLASE; I KAPPA B; SYNAPTOTAGMIN I;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; DNA BINDING; DRUG MECHANISM; ENZYME INDUCTION; ENZYME INHIBITION; HISTAMINE METABOLISM; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; BENZAMIDES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE; CELL NUCLEUS; CYCLOHEXANONES; HISTAMINE; HISTIDINE DECARBOXYLASE; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; TRANSCRIPTION FACTOR RELA; TRANSCRIPTIONAL ACTIVATION;

EID: 58149497007     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.12.065     Document Type: Article

References (39)

1. Al-Naemi H., and Baldwin A.L. Nitric oxide: role in venular permeability recovery after histamine challenge. Am. J. Physiol. 277 (1999) H2010-H2016
2. Moy A.B., Van Engelenhoven J., Bodmer J., Kamath J., Keese C., Giaever I., Shasby S., and Shasby D.M. Histamine and thrombin modulate endothelial focal adhesion through centripetal and centrifugal forces. J. Clin. Invest. 97 (1996) 1020-1027
3. Miyata K., Kamato T., Fujihara A., and Takeda M. Selective and competitive histamine H2-receptor blocking effect of famotidine on the blood pressure response in dogs and the acid secretory response in rats. Jpn. J. Pharmacol. 54 (1990) 197-204
4. Knigge U., and Warberg J. The role of histamine in the neuroendocrine regulation of pituitary hormone secretion. Acta Endocrinol. 124 (1991) 609-619
5. Falus A., and Merétey K. Histamine: an early messenger in inflammatory and immune reactions. Immunol. Today 13 (1992) 154-156
6. Ghosh A.K., Hirasawa N., Ohtsu H., Watanabe T., and Ohuchi K. Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J. Exp. Med. 195 (2002) 973-982
7. Tanaka S., Deai K., Konomi A., Takahashi K., Yamane H., Sugimoto Y., and Ichikawa A. Expression of l-histidine decarboxylase in granules of elicited mouse polymorphonuclear leukocytes. Eur. J. Immunol. 34 (2004) 1472-1482
8. Shiraishi M., Hirasawa N., Oikawa S., Kobayashi Y., and Ohuchi K. Analysis of histamine-producing cells at the late phase of allergic inflammation in rats. Immunology 99 (2000) 600-606
9. Aoi R., Nakashima I., Kitamura Y., Asai H., and Nakano K. Histamine synthesis by mouse T lymphocytes through induced histidine decarboxylase. Immunology 66 (1989) 219-223
10. Wu X., Yoshida A., Sasano T., Iwakura Y., and Endo Y. Histamine production via mast cell-independent induction of histidine decarboxylase in response to lipopolysaccharide and interleukin-1. Int. Immunopharmacol. 4 (2004) 513-520
11. Yokoyama M., Yokoyama A., Mori S., Takahashi H.K., Yoshino T., Watanabe T., Watanabe T., Ohtsu H., and Nishibori M. Inducible histamine protects mice from P. acnes-primed and LPS-induced hepatitis through H2-receptor stimulation. Gastroenterology 127 (2004) 892-902
12. Takamatsu S., Nakashima I., and Nakano K. Modulation of endotoxin-induced histamine synthesis by cytokines in mouse bone marrow-derived macrophages. J. Immunol. 156 (1996) 778-785
13. Zauberman H., Michaelson I.C., Bergmann F., and Maurice D.M. Stimulation of neovascularization of the cornea by biogenic amines. Exp. Eye Res. 8 (1969) 77-83
14. Medina V., Croci M., Crescenti E., Mohamad N., Sanchez-Jiménez F., Massari N., Nuñez M., Cricco G., Martin G., Bergoc R., and Rivera E. The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment. Cancer Biol. Ther. 7 (2008) 36-37
15. Ghosh A.K., Hirasawa N., and Ohuchi K. Enhancement by histamine of vascular endothelial growth factor production in granulation tissue via H(2) receptors. Br. J. Pharmacol. 134 (2001) 1419-1428
16. Higuchi S., Tanimoto A., Arima N., Xu H., Murata Y., Hamada T., Makishima K., and Sasaguri Y. Effects of histamine and interleukin-4 synthesized in arterial intima on phagocytosis by monocytes/macrophages in relation to atherosclerosis. FEBS Lett. 505 (2001) 217-222
17. Sasaguri Y., and Tanimoto A. Role of macrophage-derived histamine in atherosclerosis. Chronic participation in the inflammatory response. J. Atheroscler. Thromb. 11 (2004) 122-130
18. Nakamura M., Ando T., Abe M., Kumagai K., and Endo Y. Contrast between effects of aminobisphosphonates and non-aminobisphosphonates on collagen-induced arthritis in mice. Br. J. Pharmacol. 119 (1996) 205-212
19. Shiraishi M., Hirasawa N., Kobayashi Y., Oikawa S., Murakami A., and Ohuchi K. Participation of mitogen-activated protein kinase in thapsigargin- and TPA-induced histamine production in murine macrophage RAW 264.7 cells. Br. J. Pharmacol. 129 (2000) 515-524
20. Hirasawa N., Torigoe M., Ohgawara R., Murakami A., and Ohuchi K. Involvement of MAP kinases in lipopolysaccharide-induced histamine production in RAW 264 cells. Life Sci. 80 (2006) 36-42
21. Ohgoh M., Yamamoto J., Kawata M., Yamamura I., Fukui T., and Ichikawa A. Enhanced expression of the mouse l-histidine decarboxylase gene with a combination of dexamethasone and 12-O-tetradecanoylphorbol-13-acetate. Biochem. Biophys. Res. Commun. 196 (1993) 1113-1119
22. Cortés-Canteli M., Wagner M., Ansorge W., and Pérez-Castillo A. Microarray analysis supports a role for ccaat/enhancer-binding protein-beta in brain injury. J. Biol. Chem. 279 (2004) 14409-14417
23. Ariga A., Namekawa J., Matsumoto N., Inoue J., and Umezawa K. Inhibition of tumor necrosis factor-alpha -induced nuclear translocation and activation of NF-kappa B by dehydroxymethylepoxyquinomicin. J. Biol. Chem. 277 (2002) 24625-24630
24. Suzuki Y., Sugiyama C., Ohno O., and Umezawa K. Preparation and biological activities of optically active dehydroxymethylepoxyquinomicin, a novel NF-κB inhibitor. Tetrahedron 60 (2004) 7061-7066
25. Yamamoto M., Horie R., Takeiri M., Kozawa I., and Umezawa K. Inactivation of NF-κB components by covalent binding of (-)-dehydroxymethylepoxyquinomicin to specific cysteine residues. J. Med. Chem. 51 (2008) 5780-5788
26. Umezawa K. Inhibition of tumor growth by NF-κB inhibitors. Cancer Sci. 97 (2006) 990-995
27. Suzuki E., and Umezawa K. Inhibition of macrophage activation and phagocytosis by a novel NF-kappa B inhibitor, dehydroxymethylepoxyquinomicin. Biomed. Pharmacother. 60 (2006) 578-586
28. Stein B., Cogswell P.C., and Baldwin Jr. A.S. Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. Mol. Cell. Biol. 13 (1993) 3964-3974
29. Bradley M.N., Zhou L., and Smale S.T. C/EBPβ regulation in lipopolysaccharide-stimulated macrophages. Mol. Cell. Biol. 23 (2003) 4841-4858
30. Matsusaka T., Fujikawa K., Nishio Y., Mukaida N., Matsushima K., Kishimoto T., and Akira S. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines interleukin 6 and interleukin 8. Proc. Natl. Acad. Sci. USA 90 (1993) 10193-10197
31. Kunsch C., Lang R.K., Rosen C.A., and Shannon M.F. Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6. J. Immunol. 153 (1994) 153-164
32. Lee A.K., Sung S.H., Kim Y.C., and Kim S.G. Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-alpha and COX-2 expression by sauchinone effects on I-kappa B alpha phosphorylation, C/EBP and AP-1 activation. Br. J. Pharmacol. 139 (2003) 11-20
33. S.E. Zaki, Two main control elements are responsible for the activation of the murine interleukin 12 p40 promoter: studies reveal C/EBPβ and C/EBPδ to have trans-activation functions, J. Young Invest. 3 (2001) (Epub ahead of print).
34. Chen J., Zhao M., Rao R., Inoue H., and Hao C.M. C/EBPβ and its binding element are required for NF-κB-induced COX2 expression following hypertonic stress. J. Biol. Chem. 280 (2005) 16354-16359
35. Gorgoni B., Caivano M., Arizmendi C., and Poli V. The transcription factor C/EBPbeta is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts. J. Biol. Chem. 276 (2001) 40769-40777
36. Aggarwal A., Cha-Molstad H., Samols D., and Kushner I. Transactivation of C-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer binding protein beta (C/EBP beta) and Rel p50. J. Immunol. 166 (2001) 2378-2384
37. Liu Y.W., Chen C.C., Wang J.M., Chang W.C., Huang Y.C., Chung S.Y., Chen B.K., and Hung J.J. Role of transcriptional factors Sp1, c-Rel, and c-Jun in LPS-induced C/EBP delta gene expression of mouse macrophages. Cell. Mol. Life Sci. 64 (2007) 3282-3294
38. Sakuta T., Matsushita K., Yamaguchi N., Oyama T., Motani R., Koga T., Nagaoka S., Abeyama K., Maruyama I., Takada H., and Torii M. Enhanced production of vascular endothelial growth factor by human monocytic cells stimulated with endotoxin through transcription factor SP-1. J. Med. Microbiol. 50 (2001) 233-237
39. Lee K.W., Lee Y., Kwon H.J., and Kim D.S. Sp1-associated activation of macrophage inflammatory protein-2 promoter by CpG-oligodeoxynucleotide and lipopolysaccharide. Cell. Mol. Life Sci. 62 (2005) 188-198